Eli Lilly Stock Surges on Obesity Treatment Outlook
Markets & Money Today | 2 Min News | The Daily News Now! - Un pódcast de The Daily News Now! - Martes
Categorías:
Eli Lillys stock surged following Leerink Partners upgrade to Outperform, raising price target to $1,104, driven by anticipated obesity treatment adoption and Medicare/Medicaid expansion. Shares closed at $969.48, a 4.9% increase, marking a new fifty-two-week high and a 24.6% YTD gain. Long-term investors have seen a sixfold return over five years.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
